Dilan Athauda

4.2k citations
53 papers · 3.4k · 4 hit papers · h-index 26

Impact in

  • Neurology top 0.5%
    • Parkinson's Disease Mechanisms and Treatments
    • Neuroinflammation and Neurodegeneration Mechanisms
    • Neurological disorders and treatments
    • Long-Term Effects of COVID-19
    • Diabetes Treatment and Management

Papers in

    • Parkinson's Disease Mechanisms and Treatments 37
    • Neurological disorders and treatments 6
    • Autoimmune Neurological Disorders and Treatments 2
    • Long-Term Effects of COVID-19 2
    • Undergraduate Neuroscience Education and Research 1

Dilan Athauda

49 papers receiving 3.4k citations

Dilan Athauda's Hit Papers

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial 2025 · 94 citations
940+3+6Years since publication200400600

Peers

Dilan Athauda
Comparison fields: 5 of 100
  • Neurology 2.1k
  • Neurology 234
  • Endocrinology, Diabetes and Metabolism 350
  • Physiology 480
  • Aging 21
Replace Georgia Xiromerisiou with:
Georgia Xiromerisiou Greece
Taku Hatano Japan
Haiyan Zhou China
Nicola Tambasco Italy
Huidong Tang China
Yuyan Tan China
Eng King Tan Singapore
Yu-Hui Liu China
Mingwei Li China
Dilan Athauda relative to Georgia Xiromerisiou Greece Georgia Xiromerisiou's profile →
Citations per field
00.5×2×3×3.9×
Georgia Xiromerisiou · 1×
Citations per year

Countries citing papers authored by Dilan Athauda

Since Specialization
Citations

This map shows the geographic impact of Dilan Athauda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dilan Athauda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dilan Athauda more than expected).

Fields of papers citing papers by Dilan Athauda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dilan Athauda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dilan Athauda. The network helps show where Dilan Athauda may publish in the future.

Co-authors

The 25 scholars most cited alongside Dilan Athauda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dilan Athauda Line = papers co-authored together Dilan Athauda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Hit paper breakdown →
2017723
2
The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action
Hit paper breakdown →
2016334
3 2016285
4 2014222
5 2019213
6
Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity
Hit paper breakdown →
2022190
7 2020185
8
Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
Hit paper breakdown →
202594
9 202293
10 201787
11 201867
12 201865
13 202164
14 201657
15 201652
16 201752
17 201848
18 201848
19 202247
20 201945

About Dilan Athauda

Dilan Athauda is a scholar working on Neurology, Cognitive Neuroscience, Endocrinology, Diabetes and Metabolism, Physical Therapy, Sports Therapy and Rehabilitation and Physiology, having authored 53 papers that have together received 3.4k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (37 papers), Neurological disorders and treatments (6 papers), Autoimmune Neurological Disorders and Treatments (2 papers), Alzheimer's disease research and treatments (2 papers), Long-Term Effects of COVID-19 (2 papers), Diabetes Treatment and Management (2 papers), Undergraduate Neuroscience Education and Research (1 paper) and Innovations in Medical Education (1 paper). The work is most often cited by research in Neurology (2.1k citations), Neurology (234 citations), Endocrinology, Diabetes and Metabolism (350 citations), Physiology (480 citations) and Aging (21 citations). Dilan Athauda has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Thomas Foltynie, Kashfia Chowdhury, Simon S. Skene, Patricia Dowsey Limousin, Nigel H. Greig, Yazhou Li, Icíar Avilés-Olmos, Kate Maclagan, Natalia Budnik and Steve Hibbert. Their work appears in journals such as Movement Disorders, Journal of Parkinson s Disease, Brain Communications, Journal of Neurology Neurosurgery & Psychiatry and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact